NAMSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NAMSW
NewAmsterdam Pharma Co N.V.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$20.47+0.64 (+3.23%)
Close on Oct 19, 2026
- Market cap
- $2.53B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of NewAmsterdam Pharma's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 29, 2026 | Sep 29, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 21, 2026 | Sep 21, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 10, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2026 | Aug 5, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 24, 2026 | Jul 24, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 16, 2026 | Jul 22, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 2, 2026 | Jun 3, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | May 6, 2026 | May 6, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 20, 2026 | Apr 24, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 2, 2026 | Mar 2, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 18, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 18, 2026 | Feb 18, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 9, 2026 | Jan 9, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2025 | Nov 5, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 2, 2025 | Sep 2, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 18, 2025 | Aug 18, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2025 | Aug 15, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 30, 2025 | Jul 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 11, 2025 | Jul 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2025 | Jun 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 9, 2025 | Jun 9, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2025 | Jun 6, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 4, 2025 | May 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | May 7, 2025 | May 7, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 15, 2025 | Apr 17, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 26, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2025 | Feb 26, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 10, 2025 | Jan 10, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2024 | Dec 13, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 10, 2024 | Dec 10, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 10, 2024 | Dec 10, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 20, 2024 | Nov 20, 2024 | SEC EDGAR |